Compare, Analyse Fresenius Kabi Onco. with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FRESENIUS KABI ONCO. vs ACTAVIS (US) - Comparison Results

FRESENIUS KABI ONCO.     Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FRESENIUS KABI ONCO.   ACTAVIS
EQUITY SHARE DATA
    FRESENIUS KABI ONCO.
Mar-13
ACTAVIS
Dec-18
FRESENIUS KABI ONCO./
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs17614,139-   
Low Rs799,484-   
Sales per share (Unadj.) Rs37.73,468.3-  
Earnings per share (Unadj.) Rs5.1-1,117.1-  
Cash flow per share (Unadj.) Rs6.7365.5-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs42.514,305.1-  
Shares outstanding (eoy) m158.23332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.43.4 99.1%   
Avg P/E ratio x25.0-10.6 -236.3%  
P/CF ratio (eoy) x18.932.3 58.6%  
Price / Book Value ratio x3.00.8 362.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m20,1353,928,593 0.5%   
No. of employees `0001.216.9 6.8%   
Total wages/salary Rs m7030-   
Avg. sales/employee Rs Th5,176.268,257.8 7.6%   
Avg. wages/employee Rs Th610.40-   
Avg. net profit/employee Rs Th699.6-21,985.9 -3.2%   
INCOME DATA
Net Sales Rs m5,9631,153,556 0.5%  
Other income Rs m1822,060 0.1%   
Total revenues Rs m5,9811,175,616 0.5%   
Gross profit Rs m1,43030,229 4.7%  
Depreciation Rs m258493,120 0.1%   
Interest Rs m-2666,567 -0.0%   
Profit before tax Rs m1,216-507,398 -0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-68129,407 -0.1%   
Tax Rs m342-6,430 -5.3%   
Profit after tax Rs m806-371,561 -0.2%  
Gross profit margin %24.02.6 915.2%  
Effective tax rate %28.11.3 2,220.3%   
Net profit margin %13.5-32.2 -42.0%  
BALANCE SHEET DATA
Current assets Rs m5,102473,128 1.1%   
Current liabilities Rs m2,385418,545 0.6%   
Net working cap to sales %45.64.7 962.7%  
Current ratio x2.11.1 189.2%  
Inventory Days Days15020 766.1%  
Debtors Days Days11366 170.9%  
Net fixed assets Rs m5,148130,576 3.9%   
Share capital Rs m1580-   
"Free" reserves Rs m6,5560-   
Net worth Rs m6,7324,757,880 0.1%   
Long term debt Rs m9521,675,422 0.1%   
Total assets Rs m10,3887,437,649 0.1%  
Interest coverage x-45.8-6.6 691.2%   
Debt to equity ratio x0.10.4 40.2%  
Sales to assets ratio x0.60.2 370.1%   
Return on assets %7.5-4.1 -183.1%  
Return on equity %12.0-7.8 -153.3%  
Return on capital %14.6-4.8 -301.7%  
Exports to sales %74.50-   
Imports to sales %24.80-   
Net fx Rs m3,5250-   
CASH FLOW
From Operations Rs m1,274412,122 0.3%  
From Investments Rs m-1,204226,407 -0.5%  
From Financial Activity Rs m-196-707,325 0.0%  
Net Cashflow Rs m-126-68,452 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.07 Rs / USD

Compare FRESENIUS KABI ONCO. With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare FRESENIUS KABI ONCO. With: PIRAMAL ENTERPRISES  GLENMARK PHARMA  CIPLA  JUBILANT LIFE SCIENCES  PFIZER  



Today's Market

Nifty is Weak but Smallcaps Can Outperform(Momentum Moves)

The market see-sawed during the week with both the bulls and bears swinging it out. But in the end, it was the bears who won. The Nifty ended the day, the week, and the month at 14,529.15.

Related Views On News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living (Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Access Now: Eight Steps to Your Eight Figure Fortune
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

FRESENIUS KABI ONCO. SHARE PRICE


Jan 2, 2014 (Close)

TRACK FRESENIUS KABI ONCO.

  • Track your investment in FRESENIUS KABI ONCO. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON FRESENIUS KABI ONCO.

FRESENIUS KABI ONCO. - LUPIN COMPARISON

COMPARE FRESENIUS KABI ONCO. WITH

FEATURED VIDEOS

Nifty is Weak but Smallcaps Can Outperform

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

More Featured Videos

MARKET STATS